2-({3-ethyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-[(4-methoxyphenyl)methyl]acetamide

Catalog No. :
ACGSAR684
CAS No. :
1040635-49-1
Molecular Formula :
C24H23N3O3S2
Molecular Weight :
465.60

IUPAC Name:2-((3-ethyl-4-oxo-7-phenyl-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(4-methoxybenzyl)acetamide

2-({3-ethyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-[(4-methoxyphenyl)methyl]acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-({3-ethyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-[(4-methoxyphenyl)methyl]acetamide
IUPAC Name2-((3-ethyl-4-oxo-7-phenyl-3,4-dihydrothieno[3,2-d]pyrimidin-2-yl)thio)-N-(4-methoxybenzyl)acetamide
MDL No.MFCD11997110
Molecular FormulaC24H23N3O3S2
Molecular Weight465.60
SMILESO=C(NCC1=CC=C(OC)C=C1)CSC2=NC(C(C3=CC=CC=C3)=CS4)=C4C(N2CC)=O
InChI KeyDNWXSBBJJKGTSQ-UHFFFAOYSA-N
Synonym2-({3-ethyl-4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}sulfanyl)-N-[(4-methoxyphenyl)methyl]acetamide;Acetamide, 2-[(3-ethyl-3,4-dihydro-4-oxo-7-phenylthieno[3,2-d]pyrimidin-2-yl)thio]-N-[(4-methoxyphenyl)methyl]-
CAS No.1040635-49-1

Synthetic Route by SureRoute

1. ACGSAR684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGSAR684 route product structure diagram
    ACGSAR6841040635-49-1
Inquiry

2. ACGSAR684 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACOCJP406 route compound structure diagram
    ACOCJP406144581-86-2 In Stock
  4. Then
  5. ACGSAR684 route product structure diagram
    ACGSAR6841040635-49-1
Inquiry

Comments (0)